Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia · Delayed Price · Currency is SAR 94.20
-1.15 (-1.21%)
Jun 11, 2026, 3:16 PM AST
Nahdi Medical Company Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Nahdi Medical Company stock has a consensus rating of "Buy" and an average price target of SAR 125.87. The average 1-year stock price forecast is 33.62% higher than the current stock price, while the lowest is SAR 105.15 (+11.62%) and the highest is SAR 142.00 (+50.74%).
Price Target: SAR 125.87 (+33.62%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Nahdi Medical Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 9 | 9 |
Financial Forecast
Revenue This Year
10.91B
from 10.21B
Increased by 6.86%
Revenue Next Year
11.79B
from 10.91B
Increased by 8.04%
EPS This Year
6.38
from 6.39
Decreased by -0.11%
EPS Next Year
6.96
from 6.38
Increased by 9.02%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.0B | ||
| Avg | 10.9B | ||
| Low | 10.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.0% | ||
| Avg | 6.9% | ||
| Low | 4.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.48 | ||
| Avg | 6.38 | ||
| Low | 6.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4% | ||
| Avg | -0.1% | ||
| Low | -3.6% |